Publication | Closed Access
Phase 2 Study of Lutetium 177–Labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma
96
Citations
8
References
2015
Year
UrologyGenitourinary CancerMedicineCancer TreatmentPhase 2Lutetium 177–LabeledOncologyRadiation OncologyCancer ResearchMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1